The article by Giovannucci et al. in this issue of the Journal1promises an important advance in cancer prevention. An analysisof the incidence of colorectal cancer among women participatingin the Nurses' Health Study according to whether they did ordid not use aspirin on a regular basis showed a statisticallysignificant reduction in the incidence of colorectal canceramong women who took four to six aspirin tablets per week formore than 10 years. Known risk factors for colorectal cancer,such as diet, did not influence the results. Moreover, the reductionamong women ingesting aspirin was not due . . . [Full Text of this Article]
Chiang, N., Hurwitz, S., Ridker, P. M., Serhan, C. N.
(2006). Aspirin Has A Gender-Dependent Impact on Antiinflammatory 15-Epi-Lipoxin A4 Formation: A Randomized Human Trial. Arterioscler. Thromb. Vasc. Bio.
26: e14-e17
[Abstract][Full Text]
Van Dyke, T. E., Serhan, C.N.
(2003). Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases. J. Dent. Res.
82: 82-90
[Abstract][Full Text]
Thun, M. J., Henley, S. J., Patrono, C.
(2002). Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues. JNCI J Natl Cancer Inst
94: 252-266
[Abstract][Full Text]
Fierro, I. M., Kutok, J. L., Serhan, C. N.
(2002). Novel Lipid Mediator Regulators of Endothelial Cell Proliferation and Migration: Aspirin-Triggered-15R-Lipoxin A4 and Lipoxin A4. J. Pharmacol. Exp. Ther.
300: 385-392
[Abstract][Full Text]
Blacklock, C J, Lawrence, J R, Wiles, D, Malcolm, E A, Gibson, I H, Kelly, C J, Paterson, J R
(2001). Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J. Clin. Pathol.
54: 553-555
[Abstract][Full Text]
Ota, H., Igarashi, S., Sasaki, M., Tanaka, T.
(2001). Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod
16: 561-566
[Abstract][Full Text]
Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N., Serhan, C. N.
(2001). Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory Responses. Am. J. Pathol.
158: 3-9
[Abstract][Full Text]
Serhan, C. N, Clish, C. B
(2000). Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking. Thorax
55: 10S-12
[Full Text]
Chiang, N., Fierro, I. M., Gronert, K., Serhan, C. N.
(2000). Activation of Lipoxin A4 Receptors by Aspirin-triggered Lipoxins and Select Peptides Evokes Ligand-specific Responses in Inflammation. J. Exp. Med.
191: 1197-1208
[Abstract][Full Text]
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., West, A. B.
(1999). Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. Cell Physiol.
277: C183-C201
[Abstract][Full Text]
Clish, C. B., O'Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., Serhan, C. N.
(1999). Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA
96: 8247-8252
[Abstract][Full Text]
LEVY, B. D., FOKIN, V. V., CLARK, J. M., WAKELAM, M. J. O., PETASIS, N. A., SERHAN, C. N.
(1999). Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a `stop' signaling switch for aspirin-triggered lipoxin A4. FASEB J.
13: 903-911
[Abstract][Full Text]
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Boucher, P., Mamelle, N.
(1998). Mediterranean Dietary Pattern in a Randomized Trial: Prolonged Survival and Possible Reduced Cancer Rate. Arch Intern Med
158: 1181-1187
[Abstract][Full Text]
Goldberg, Y., Marcus, A. J., Broekman, M. J.
(1996). Aspirin and Colon Cancer. NEJM
334: 800-801
[Full Text]
Johnson, K. A., Prindiville, S. A., Morgan, G., Roychowdhury, D. F., van Bodegraven, A.A., Lourens, J., Sindram, J.W., Kaufmann, H. J., Schuler, M., Giovannucci, E., Speizer, F. E., Egan, K., Marcus, A. J.
(1996). Aspirin and the Risk of Colorectal Cancer in Women. NEJM
334: 119-122
[Full Text]